Clinical Meaningfulness in Alzheimer’s Disease Trials: Key Insights from the EU-US CTAD Task Force Report
Clinical Meaningfulness in Alzheimer’s Disease Trials: Key Insights from the EU-US CTAD Task Force Report ALZHEIMER’S DISEASE STUDY HIGHLIGHTS – Clinical Meaningfulness in Alzheimer’s Disease Clinical Trials. A Report from the EU-US CTAD Task Force by Angioni,...
Creating a Greener Workplace: Moleac’s Commitment to Sustainability
Creating a Greener Workplace: Moleac’s Commitment to Sustainability At Moleac, we are dedicated to sustainability, and we are excited to share the steps we are taking to create an eco-friendly workplace! From cutting back on air conditioning to ensuring monitors are...
Today is World Alzheimer’s Day: Raising Awareness and Helping Patients Reconnect with Their Lives
Today is World Alzheimer’s Day: Raising Awareness and Helping Patients Reconnect with Their Lives Today is World Alzheimer’s Day!Every year on September 21st, World Alzheimer’s Day offers a meaningful opportunity to raise awareness about Alzheimer’s disease and to...
Discontinuation of Nutrimore Neuropar – Joint Statement from Moleac and PT Prima Medika Laboratories
Discontinuation of Nutrimore Neuropar – Joint Statement from Moleac and PT Prima Medika Laboratories ANNOUNCEMENT – INDONESIAWe are pleased to share a joint statement from Moleac Pte. Ltd. and PT Prima Medika Laboratories (PML). “To whom it may concern,PML would like...
